Synthetic mRNA Production Landscape Assessment

Project Overview

A UK-based life science services provider was interested in learning more about the value and market landscape for synthetic mRNA production to inform a potential acquisition strategy

DeciBio Approach

Secondary Research

Aggregated secondary research of the therapeutic mRNA space and market demand for manufacturing
Summarized key specifications required and demand drivers for external manufacturing
Assessed the CMO competitive landscape

‍Primary Research

Conducted 12 in-depth stakeholder interviews with biopharma stakeholders with direct experience synthesizing and using mRNA for therapeutic applications
Interviewees included experts across public and private biopharma who utilize mRNA for a diverse range of therapeutic applications

Quantitative Analysis

Built a bottoms-up model estimating the demand and production level of synthetic mRNA today and in five years within biopharma by application area and phase of development

‍

At a glance

Stakeholder Interviews

mRNA Clinical Trials Analyzed

Biopharma Companies Profiled

Outcomes

DeciBio shared research findings with the client, key takeaways included:

Estimated opportunity for external mRNA manufacturing in 2019 and 2024.
Outlined customer requirements and key considerations and recommendations to help inform the client’s acquisition strategy

‍

Timeline

3 weeks

Geographic Scope

U.S., EU

Industry

Pharma & Biotech

capabilities

Voice-Of-Customer Research

Competitive Analysis

Addressable Market Sizing

Cell and Gene Therapy Services Landscape Assessment

Cell and Gene Therapy Service Market Opportunity Assessment

Synthetic Oligonucleotides Market Sizing